HELEN OF TROY LTD (HELE) Fundamental Analysis & Valuation

NASDAQ:HELE • BMG4388N1065

Current stock price

23.62 USD
-0.2 (-0.84%)
At close:
23.62 USD
0 (0%)
After Hours:

This HELE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HELE Profitability Analysis

1.1 Basic Checks

  • In the past year HELE was profitable.
  • HELE had a positive operating cash flow in the past year.
  • Of the past 5 years HELE 4 years were profitable.
  • HELE had a positive operating cash flow in 4 of the past 5 years.
HELE Yearly Net Income VS EBIT VS OCF VS FCFHELE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -33.86%, HELE is doing worse than 95.00% of the companies in the same industry.
  • With a Return On Equity value of -92.99%, HELE is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
  • HELE has a Return On Invested Capital (6.68%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HELE is in line with the industry average of 9.06%.
Industry RankSector Rank
ROA -33.86%
ROE -92.99%
ROIC 6.68%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
HELE Yearly ROA, ROE, ROICHELE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • In the last couple of years the Profit Margin of HELE has declined.
  • The Operating Margin of HELE (8.21%) is better than 63.33% of its industry peers.
  • In the last couple of years the Operating Margin of HELE has declined.
  • HELE's Gross Margin of 46.72% is amongst the best of the industry. HELE outperforms 86.67% of its industry peers.
  • HELE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.21%
PM (TTM) N/A
GM 46.72%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
HELE Yearly Profit, Operating, Gross MarginsHELE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1

2. HELE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HELE is destroying value.
  • There is no outstanding debt for HELE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HELE Yearly Shares OutstandingHELE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
HELE Yearly Total Debt VS Total AssetsHELE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • HELE has an Altman-Z score of 1.71. This is a bad value and indicates that HELE is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of HELE (1.71) is worse than 78.33% of its industry peers.
  • HELE has a debt to FCF ratio of 15.97. This is a negative value and a sign of low solvency as HELE would need 15.97 years to pay back of all of its debts.
  • The Debt to FCF ratio of HELE (15.97) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that HELE has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.02, HELE is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 15.97
Altman-Z 1.71
ROIC/WACC0.7
WACC9.52%
HELE Yearly LT Debt VS Equity VS FCFHELE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • HELE has a Current Ratio of 1.81. This is a normal value and indicates that HELE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of HELE (1.81) is worse than 71.67% of its industry peers.
  • HELE has a Quick Ratio of 1.81. This is a bad value and indicates that HELE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HELE has a worse Quick ratio (0.90) than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.9
HELE Yearly Current Assets VS Current LiabilitesHELE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2

3. HELE Growth Analysis

3.1 Past

  • The earnings per share for HELE have decreased strongly by -50.83% in the last year.
  • Measured over the past years, HELE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.17% on average per year.
EPS 1Y (TTM)-50.83%
EPS 3Y-27.89%
EPS 5Y-21.17%
EPS Q2Q%-64.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.49% on average over the next years.
  • Based on estimates for the next years, HELE will show a small growth in Revenue. The Revenue will grow by 2.01% on average per year.
EPS Next Y-3.4%
EPS Next 2Y7.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.89%
Revenue Next 2Y2.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
HELE Yearly Revenue VS EstimatesHELE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HELE Yearly EPS VS EstimatesHELE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

6

4. HELE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.67 indicates a rather cheap valuation of HELE.
  • Compared to the rest of the industry, the Price/Earnings ratio of HELE indicates a rather cheap valuation: HELE is cheaper than 93.33% of the companies listed in the same industry.
  • HELE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.42.
  • HELE is valuated cheaply with a Price/Forward Earnings ratio of 6.91.
  • 96.67% of the companies in the same industry are more expensive than HELE, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of HELE to the average of the S&P500 Index (22.24), we can say HELE is valued rather cheaply.
Industry RankSector Rank
PE 6.67
Fwd PE 6.91
HELE Price Earnings VS Forward Price EarningsHELE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HELE is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, HELE is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.75
EV/EBITDA 6.98
HELE Per share dataHELE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.49%
EPS Next 3YN/A

0

5. HELE Dividend Analysis

5.1 Amount

  • No dividends for HELE!.
Industry RankSector Rank
Dividend Yield 0%

HELE Fundamentals: All Metrics, Ratios and Statistics

HELEN OF TROY LTD

NASDAQ:HELE (4/24/2026, 8:00:01 PM)

After market: 23.62 0 (0%)

23.62

-0.2 (-0.84%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)04-23
Earnings (Next)N/A
Inst Owners101.55%
Inst Owner Change-0.69%
Ins Owners2.14%
Ins Owner Change24.6%
Market Cap544.91M
Revenue(TTM)N/A
Net Income(TTM)-792.50M
Analysts76
Price Target20.66 (-12.53%)
Short Float %13.99%
Short Ratio5.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.95%
Min EPS beat(2)-2.08%
Max EPS beat(2)9.97%
EPS beat(4)1
Avg EPS beat(4)-12.41%
Min EPS beat(4)-52.71%
Max EPS beat(4)9.97%
EPS beat(8)4
Avg EPS beat(8)-8.68%
EPS beat(12)7
Avg EPS beat(12)-3.46%
EPS beat(16)11
Avg EPS beat(16)-0.36%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.16%
Max Revenue beat(2)1.08%
Revenue beat(4)1
Avg Revenue beat(4)-2.08%
Min Revenue beat(4)-7.92%
Max Revenue beat(4)1.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.13%
Revenue beat(12)5
Avg Revenue beat(12)-1.23%
Revenue beat(16)7
Avg Revenue beat(16)0.42%
PT rev (1m)-10.99%
PT rev (3m)19.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.76%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)-4.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.67
Fwd PE 6.91
P/S 0.3
P/FCF 9.75
P/OCF 5.75
P/B 0.64
P/tB N/A
EV/EBITDA 6.98
EPS(TTM)3.54
EY14.99%
EPS(NY)3.42
Fwd EY14.48%
FCF(TTM)2.42
FCFY10.25%
OCF(TTM)4.11
OCFY17.4%
SpS78.12
BVpS36.94
TBVpS-3.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number54.2444 (129.65%)
Profitability
Industry RankSector Rank
ROA -33.86%
ROE -92.99%
ROCE 8.28%
ROIC 6.68%
ROICexc 6.78%
ROICexgc 14.36%
OM 8.21%
PM (TTM) N/A
GM 46.72%
FCFM 3.1%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
ROICexc(3y)7.81%
ROICexc(5y)9.62%
ROICexgc(3y)23.08%
ROICexgc(5y)29.38%
ROCE(3y)9.64%
ROCE(5y)11.77%
ROICexgc growth 3Y-15.74%
ROICexgc growth 5Y-12.1%
ROICexc growth 3Y-13.74%
ROICexc growth 5Y-11.08%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 15.97
Debt/EBITDA 4.3
Cap/Depr 72.11%
Cap/Sales 2.16%
Interest Coverage 250
Cash Conversion 46.94%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.9
Altman-Z 1.71
F-Score3
WACC9.52%
ROIC/WACC0.7
Cap/Depr(3y)172.35%
Cap/Depr(5y)199.35%
Cap/Sales(3y)3.95%
Cap/Sales(5y)4.01%
Profit Quality(3y)83.41%
Profit Quality(5y)72.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-50.83%
EPS 3Y-27.89%
EPS 5Y-21.17%
EPS Q2Q%-64.38%
EPS Next Y-3.4%
EPS Next 2Y7.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.26%
Revenue Next Year0.89%
Revenue Next 2Y2.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.67%
EBIT growth 3Y-7.86%
EBIT growth 5Y-0.78%
EBIT Next Year-24.72%
EBIT Next 3Y-4.67%
EBIT Next 5YN/A
FCF growth 1Y-83.21%
FCF growth 3Y9.8%
FCF growth 5Y-19.99%
OCF growth 1Y-75.77%
OCF growth 3Y-7.01%
OCF growth 5Y-16.04%

HELEN OF TROY LTD / HELE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HELEN OF TROY LTD (HELE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HELE.


Can you provide the valuation status for HELEN OF TROY LTD?

ChartMill assigns a valuation rating of 6 / 10 to HELEN OF TROY LTD (HELE). This can be considered as Fairly Valued.


Can you provide the profitability details for HELEN OF TROY LTD?

HELEN OF TROY LTD (HELE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HELEN OF TROY LTD (HELE) stock?

The Price/Earnings (PE) ratio for HELEN OF TROY LTD (HELE) is 6.67 and the Price/Book (PB) ratio is 0.64.


What is the financial health of HELEN OF TROY LTD (HELE) stock?

The financial health rating of HELEN OF TROY LTD (HELE) is 1 / 10.